|
The prevalence of hypothyroidism in the IFN-naïve and IFN-treated HCV patients compared with the general populations. The prevalence of elevated TSH levels in the various population groups include: Australia ~2.0% [17], the United States of America ~7.3% [18], Spain ~2.0% [18], Japan ~1.3% [18], Great Britain ~7.3% [18] and Italy ~1.7% [19] |
||
| Studies N = number of subjects |
Prevalence of hypothyroidism (before IFN) |
Prevalence of hypothyroidism (after IFN) |
|
|
||
| Marcellin et al. [5] N = 74 |
0 |
7.2 |
| Preziati et al. [15] N = 78 |
0 |
22.8 |
| Imigawa et al. [14] N = 58 |
0 |
3.4 |
| Marazuela et al. [7] N = 207 |
4.7 |
2.8 |
| This work N = 272 |
1.1% |
7.5% |
| Baudin et al. [16] N = 68 |
0 |
7.3 |
| Antonelli et al. [13] N = 630 |
13% |
N/A |
Tran et al. BMC Endocrine Disorders 2005 5:8 doi:10.1186/1472-6823-5-8 |
||